Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology

Osteonecrosis of the jaw (ONJ) is a well-known pathological condition in oncology derived from the use of bisphosphonates (BPs) and denosumab. Many molecular and immunological targets have been introduced for daily use in cancer treatment in recent years; consequently, new cases of ONJ have been rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Nifosì, Antonio Fabrizio, Zuccarello, Mariateresa, Nifosì, Lorenzo, Hervas Saus, Vanessa, Nifosì, Gianfilippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Oral and Maxillofacial Surgeons 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400698/
https://www.ncbi.nlm.nih.gov/pubmed/30847290
http://dx.doi.org/10.5125/jkaoms.2019.45.1.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400698/
https://www.ncbi.nlm.nih.gov/pubmed/30847290
http://dx.doi.org/10.5125/jkaoms.2019.45.1.3

Ejemplares similares